Trial intelligence / Profile preview

Intranasal Sufentanil and Ketamine for Procedural Pain in Children

NCT01047241Phase 2Completed

Sponsor
Danmarks Farmaceutiske Universitet
Start
Apr 2010
Primary completion
Feb 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of sufentanil, ketamine transdermal patch in procedural pain, sponsored by Danmarks Farmaceutiske Universitet. Started Apr 2010; status: completed.

02

Drugs

sufentanilketamine transdermal patch
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT01047241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01047241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call